2020-2027 Analysis and Review Metronidazole Market
Metronidazole Market By Treatment (Bacterial Vaginosis, Rosacea, Amoebiasis and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027
The metronidazole market was valued at USD1,377.3Mn by 2019. Rising prevalence of bacterial and parasitic infection worldwide drive the metronidazole market growth. It is still considered as a first-line therapy in bacterial vaginosis, rosacea, amoebiasis, etc. A constant rise in the generic drug market in the developing region further accentuates metronidazole market growth.
Metronidazole belongs to the nitroimidazole class of antibiotics which is used for the treatment of giardiasis, trichomoniasis, amoebiasis, and other parasitic infections. The exact mechanism of action is not known but an intermediate of metronidazole binds to the DNA and electron transport proteins of the microorganism and blocks the synthesis of nucleic acids. It is available as tablets, capsules, topical gels, intravenous fluids with different dose strengths, etc.
The major segments related to the metronidazole market are:
By Treatment (2017–2027; US$ Mn)
Bacterial Vaginosis
Rosacea
Amoebiasis
Others
By Distribution Channel (2017–2027; US$ Mn)
Hospital Pharmacy
Retail Pharmacy
Others
Geography Segment(2017–2027; US$ Mn)
North America
United States
Canada
Europe
United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America (LATAM)
Brazil
Mexico
Rest of Latin America
Middle East and Africa (MEA)
GCC
Rest of MEA
Justification for study?
Report gist?
Significant customers?
Segment Analysis
Bacterial vaginosis is reigning the treatment segment for the metronidazole market. According to the latest research citings presented by the World Health Organization (WHO), approximately 30% of the women population aged 14 to 49 years experience with bacterial vaginosis infection. It is associated with risk factors such as sexually transmitted diseases, such as syphilis, gonorrhea, AIDS, chlamydia, herpes simplex, etc. Bacterial vaginosis produces a bad odor which leads to grave embarrassment and low self-esteem in women suffering from the disease. Rosacea is anticipated to be the fastest-growing treatment segment in the near future on account of the constant rise in the reported cases in the people belonging to European and Celtic descent. According to the research citings presented by the European Society for Dermatological Research (ESDR), approximately 400 million people worldwide are suffering from rosacea. Constant exposure to extreme cold and heat triggers the occurrence of rosacea in the central part of the face, additionally, alcohol consumption and cigarette smoking further aggravates the situation.
Hospital pharmacy is dominating the distribution channel segment for the metronidazole market. Precise compounding of metronidazole is essential as it is used as a first-line therapy drug in bacterial and parasitic infection. Hospital pharmacist ensures accurate dispensing of metronidazole drug formulation in accordance with the physicians prescription. Retail pharmacy is gaining huge demand in developing countries in order to cater to the medicinal needs of a huge population base and availability of generic drugs at attractive prices.
North America is holding the largest market share in the geography segment for the metronidazole market. Rising prevalence of bacterial vaginosis in women population aged 14 to 49 primarily drives the metronidazole market growth in the region. As per the latest statistics provided by the Center for Disease Control and Prevention (CDC), approximately 21.2 million women population in the United States are suffering from bacterial vaginosis. Additionally constant rise in the reported cases of pelvic inflammatory disease further accentuates the market growth in the region. Europe is currently in second place in the regional segment for the metronidazole market. According to the latest research information brought forward by the European Commission the prevalence rate of rosacea is ranging from 9 to 22%, it is highly prevalent in the Caucasian population and has a high incidence rate in the female population in comparison to males. The Asia Pacific is keen to register excellent market growth during the forecast period on account of the rising prevalence of amoebiasis infection across all age groups and the existence of a well-developed generic drug market in the region.
$4,600 | |
$6,600 | |
$9,500 |
Request customization |
Get market alerts |
Ask for regional data |
Ask for country-specific data |